anmelden
OMX Stockholm 30
3.258,14
PKT
+55,71
PKT
+1,74
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.12.18 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 17.12.18 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 17.12.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 17.12.18 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 17.12.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 17.12.18 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 14.12.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 13.12.18 | Volvo (B) buy | Kepler Cheuvreux | |
| 13.12.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 12.12.18 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 11.12.18 | Volvo (B) Sell | UBS AG | |
| 11.12.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.12.18 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 10.12.18 | ABB (Asea Brown Boveri) buy | HSBC | |
| 08.12.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 07.12.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 06.12.18 | Volvo (B) Underweight | Morgan Stanley | |
| 05.12.18 | ABB (Asea Brown Boveri) neutral | Morgan Stanley | |
| 03.12.18 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.11.18 | AstraZeneca Reduce | HSBC | |
| 23.11.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 19.11.18 | AstraZeneca Neutral | UBS AG | |
| 19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 19.11.18 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.11.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.18 | AstraZeneca Reduce | HSBC | |
| 12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.11.18 | AstraZeneca Hold | CFRA | |
| 09.11.18 | AstraZeneca overweight | Barclays Capital | |
| 08.11.18 | AstraZeneca Neutral | UBS AG | |
| 08.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.11.18 | ABB (Asea Brown Boveri) Hold | Baader Bank | |
| 30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
